Arkolith/Insider Trading/PHAS/Form 4/A

Humphries William D.

DirectorPhaseBio Pharmaceuticals Inc (PHAS) · full profile →Form 4/A · filed Jun 10, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 19, 2022Grant(A)12K—$012K
May 19, 2022Grant(A)3K—$03K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001169245-22-000081) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML